Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
One older study on Byetta (exenatide) showed minimal transfer, but there are no studies on semaglutide, tirzepatide, or liraglutide in breast milk, and no data on infant outcomes when exposed via breast milk
Our oral GLP-1 formulation is designed to support appetite regulation, metabolic balance, and sustainable weight management without injections
Nonetheless, gastrointestinal adverse symptoms (e.g., nausea, vomiting) persist often, and long-term safety data are still being examined
[4] The angiogenesis concern deserves specific attention because it is the most biologically plausible theoretical risk
PloS One (2014) 9:e91163
US$ 28.44
US$ 25.01
US$ 26.88
